Europe Genotyping Market Forecast to 2031 – Regional Analysis – by Product Type (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology (Microarray, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption / MALDI-TOF, and Other Technologies), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Other Applications), and End user (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other End Users)
The Europe genotyping market was valued at US$ 8,729.90 million in 2023 and is expected to reach US$ 43,883.43 million by 2031; it is estimated to record a CAGR of 22.4% from 2023 to 2031.
Technological Advancements and Rising R&D Investments in Biotechnology and Pharmaceutical Industry Drives Europe Genotyping Market
Genotyping market players are focusing on increasing their investments in projects aimed at advancements in biotechnology to come up with better alternatives to conventional techniques.
- In January 2024, Thermo Fisher Scientific launched Axiom PangenomiX Array, offering optimal genetic coverage for pharmacogenomic research and population-scale disease studies. This array is currently the only research solution that can run four assays in one test: SNP genotyping, complete genome copies number variant detection, fixed copy number discovery, and blood and HLA typing.
- In September 2023, Bio-Rad launched new PTC Tempo 48/48 and PTC Tempo 384 thermal cyclers for sequencing, cloning, and genotyping. The PTC Tempo thermal cyclers are built with an intuitive user interface and flexible connectivity features to streamline protocol management, along with monitoring capabilities on the cloud platform.
- In January 2023, Qiagen acquired Verogen, a company that uses next-generation sequencing (NGS) techniques to drive the future of forensic investigation and human identification (HID). QIAGEN and Verogen together are expected to create opportunities to help researchers advance forensic science, thereby aiding accurate suspect identification, finding missing persons, and exonerating innocent individuals.
- In June 2022, NRGene launched Soy SNPro, a product covered under predesigned SNP sets for genotyping (DNA tests) of various crops. SNPro is an off-the-shelf complete genotyping solution that combines low-density genotyping with high-density imputation.
- In May 2022, NEOGEN Corporation and Gencove announced the launch of InfiniSEEK, an innovative and cost-effective solution for addressing difficulties involved in whole-genome sequencing and targeted SNP analyses.
Such technological breakthroughs have the potential to enable miniaturization, automation, and cost reduction. They can also aid in operational flexibility and multiparameter testing. All these benefits add to the uses and convenience of DNA sequencing, allowing clinicians to concentrate on higher-level decisions such as selecting and prioritizing therapeutic targets through various genotyping studies. Further, technological advancements in DNA sequencing, such as NGS, have enabled speedy, accurate sequencing, allowing for great productivity. Thus, the growing research and development activities, along with increasing government funding for genome-based projects, contribute to the genotyping market progress.
Europe Genotyping Market Overview
The Europe genotyping market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds the second-largest share of the global genotyping market and is expected to register a notable CAGR during the forecast period. Factors such as technological advancements, reducing prices of DNA sequencing procedures, increasing incidence of genetic diseases, and rising awareness of personalized medicine are among the factors aiding the growth of the Europe genotyping market.
Europe Genotyping Market Revenue and Forecast to 2031 (US$ Million)
Europe Genotyping Market Segmentation
The Europe genotyping market is categorized into product type, technology, application, end user, and country.
Based on product type, the Europe genotyping market is segmented into instruments, reagents and kits, bioinformatics, and genotyping services. The reagents and kits segment held the largest market share in 2023.
By technology, the Europe genotyping market is segmented into microarrays, capillary electrophoresis, sequencing, polymerase chain reaction (PCR), matrix-assisted laser desorption / MALDI-TOF, and other technologies. The polymerase chain reaction (PCR) segment held the largest market share in 2023.
Based on application, the Europe genotyping market is bifurcated into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and other applications. The diagnostics and personalized medicine segment held the largest market share in 2023.
In terms of end user, the Europe genotyping market is bifurcated into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and other end users. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023.
By country, the Europe genotyping market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe genotyping market share in 2023.
Hoffmann-La Roche Ltd, QIAGEN NV, Merck KGaA, EUROFINS GENOMICS, Thermo Fisher Scientific Inc, BioTek Instruments Inc, Illumina Inc, Danaher Corp, Bio-Rad Laboratories Inc, GE HealthCare Technologies Inc, Standard BioTools Inc, Laboratory Corp of America Holdings, Beckman Coulter Inc, BGI, Takara Bio Inc, and DiaSorin SpA. are some of the leading companies operating in the Europe genotyping market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Europe Genotyping Market Landscape
4.1 Overview
4.2 Global Market Share Analysis
4.2.1 Global Market Share (%) of Leading Players for NGS Library Preparation
4.2.2 Global Market Share (%) of Leading Player for Genotyping
4.2.3 Global Market Share (%) of Leading Player for Gene Expression
5. Europe Genotyping Market – Key Market Dynamics
5.1 Market Drivers:
5.1.1 Use in Diagnosis of Genetic and Rare Diseases
5.1.2 Technological Advancements and Rising R&D Investments in Biotechnology and Pharmaceutical Industry
5.2 Market Restraints
5.2.1 High Cost of Equipment and Shortage of Skilled Professionals
5.3 Market Opportunities
5.3.1 Expanding Range of Applications
5.4 Future Trends
5.4.1 Increasing Popularity of Personalized Medicine
5.5 Impact of Drivers and Restraints:
6. Genotyping Market – Europe Analysis
6.1 Genotyping Market Revenue (US$ Million), 2021–2031
7. Europe Genotyping Market Analysis – by Product Type
7.1 Instruments
7.1.1 Overview
7.1.2 Instruments: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reagents and Kits
7.2.1 Overview
7.2.2 Reagents and Kits: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Bioinformatics
7.3.1 Overview
7.3.2 Bioinformatics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Genotyping Services
7.4.1 Overview
7.4.2 Genotyping Services: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Genotyping Market Analysis – by Technology
8.1 Microarray
8.1.1 Overview
8.1.2 Microarray: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Capillary Electrophoresis
8.2.1 Overview
8.2.2 Capillary Electrophoresis: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Sequencing
8.3.1 Overview
8.3.2 Sequencing: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Polymerase Chain Reaction (PCR)
8.4.1 Overview
8.4.2 Polymerase Chain Reaction (PCR): Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Matrix-Assisted Laser Desorption / MALDI-TOF
8.5.1 Overview
8.5.2 Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Other Technologies
8.6.1 Overview
8.6.2 Other Technologies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9. Europe Genotyping Market Analysis – by Application
9.1 Pharmacogenomics
9.1.1 Overview
9.1.2 Pharmacogenomics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Diagnostics and Personalized Medicine
9.2.1 Overview
9.2.2 Diagnostics and Personalized Medicine: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Animal Genetics
9.3.1 Overview
9.3.2 Animal Genetics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Agricultural Biotechnology
9.4.1 Overview
9.4.2 Agricultural Biotechnology: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Other Applications
9.5.1 Overview
9.5.2 Other Applications: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10. Europe Genotyping Market Analysis – by End-user
10.1 Pharmaceutical and Biopharmaceutical Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biopharmaceutical Companies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Diagnostic and Research Laboratories
10.2.1 Overview
10.2.2 Diagnostic and Research Laboratories: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Academic Institutes
10.3.1 Overview
10.3.2 Academic Institutes: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Other End Users
10.4.1 Overview
10.4.2 Other End Users: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11. Europe Genotyping Market – Country Analysis
11.1 Europe Genotyping Market Overview
11.1.1 Europe: Genotyping Market – Revenue and Forecast Analysis – by Country
11.1.1.1 United Kingdom: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.1.1 United Kingdom: Genotyping Market Breakdown, by Product Type
11.1.1.1.2 United Kingdom: Genotyping Market Breakdown, by Technology
11.1.1.1.3 United Kingdom: Genotyping Market Breakdown, by Application
11.1.1.1.4 United Kingdom: Genotyping Market Breakdown, by End-user
11.1.1.2 Germany: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.2.1 Germany: Genotyping Market Breakdown, by Product Type
11.1.1.2.2 Germany: Genotyping Market Breakdown, by Technology
11.1.1.2.3 Germany: Genotyping Market Breakdown, by Application
11.1.1.2.4 Germany: Genotyping Market Breakdown, by End-user
11.1.1.3 France: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.3.1 France: Genotyping Market Breakdown, by Product Type
11.1.1.3.2 France: Genotyping Market Breakdown, by Technology
11.1.1.3.3 France: Genotyping Market Breakdown, by Application
11.1.1.3.4 France: Genotyping Market Breakdown, by End-user
11.1.1.4 Spain: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.4.1 Spain: Genotyping Market Breakdown, by Product Type
11.1.1.4.2 Spain: Genotyping Market Breakdown, by Technology
11.1.1.4.3 Spain: Genotyping Market Breakdown, by Application
11.1.1.4.4 Spain: Genotyping Market Breakdown, by End-user
11.1.1.5 Italy: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.5.1 Italy: Genotyping Market Breakdown, by Product Type
11.1.1.5.2 Italy: Genotyping Market Breakdown, by Technology
11.1.1.5.3 Italy: Genotyping Market Breakdown, by Application
11.1.1.5.4 Italy: Genotyping Market Breakdown, by End-user
11.1.1.6 Rest of Europe: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.6.1 Rest of Europe: Genotyping Market Breakdown, by Product Type
11.1.1.6.2 Rest of Europe: Genotyping Market Breakdown, by Technology
11.1.1.6.3 Rest of Europe: Genotyping Market Breakdown, by Application
11.1.1.6.4 Rest of Europe: Genotyping Market Breakdown, by End-user
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Genotyping Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 QIAGEN NV
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Merck KGaA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 EUROFINS GENOMICS
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioTek Instruments, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Illumina Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Danaher Corp
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Bio-Rad Laboratories Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 GE HealthCare Technologies Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Standard BioTools Inc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Laboratory Corp of America Holdings
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Beckman Coulter Inc
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 BGI
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Takara Bio Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 DiaSorin SpA
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
List of Tables
Table 1. Europe Genotyping Market Segmentation
Table 2. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 3. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 4. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by End-user
Table 6. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 7. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 8. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 9. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 10. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 11. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 12. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 13. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 14. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 15. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 16. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 17. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 18. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 19. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 20. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 21. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 22. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 23. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 24. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 25. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 26. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 27. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 28. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 29. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 30. Recent Organic Growth Strategies in Genotyping Market
Table 31. Recent Inorganic Growth Strategies in the Genotyping Market
Table 32. Glossary of Terms, Genotyping Market
List of Figures
Figure 1. Europe Genotyping Market Segmentation, by Country
Figure 2. Genotyping Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Genotyping Market Revenue (US$ Million), 2021–2031
Figure 5. Genotyping Market Share (%) – by Product Type (2023 and 2031)
Figure 6. Instruments: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Reagents and Kits: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioinformatics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Genotyping Services: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Genotyping Market Share (%) – by Technology (2023 and 2031)
Figure 11. Microarray: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Capillary Electrophoresis: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Sequencing: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Polymerase Chain Reaction (PCR): Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Other Technologies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Genotyping Market Share (%) – by Application (2023 and 2031)
Figure 18. Pharmacogenomics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Diagnostics and Personalized Medicine: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Animal Genetics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Agricultural Biotechnology: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Other Applications: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Genotyping Market Share (%) – by End-user (2023 and 2031)
Figure 24. Pharmaceutical and Biopharmaceutical Companies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 25. Diagnostic and Research Laboratories: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. Academic Institutes: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Other End Users: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Europe Genotyping Market, by Key Countries - Revenue (2023) (US$ Million)
Figure 29. Europe: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 30. United Kingdom: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 31. Germany: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. France: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Spain: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. Italy: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. Rest of Europe: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. Growth Strategies in Genotyping Market
- Hoffmann-La Roche Ltd.
- QIAGEN NV.
- Merck KGaA.
- EUROFINS GENOMICS.
- Thermo Fisher Scientific Inc.
- BioTek Instruments, Inc.
- Illumina Inc.
- Danaher Corp.
- Bio-Rad Laboratories Inc.
- GE HealthCare Technologies Inc.
- Standard BioTools Inc.
- Laboratory Corp of America Holdings.
- Beckman Coulter Inc.
- BGI.
- Takara Bio Inc.
- DiaSorin SpA.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe genotyping market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe genotyping market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe genotyping market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.